SEARCH

SEARCH BY CITATION

References

  • 1
    Riordan S, Williams R. Acute liver failure: targeted artificial and hepatocyte-based support of liver regeneration and reversal of multiorgan failure. J Hepatol 2000; 32 (Suppl. 1): 63.
  • 2
    Callery MP, Mangino MM, Flye MW. Arginine-specific suppression of mixed lymphocyte culture reactivity by Kupffer cells-a basis of portal venous tolerance. Transplantation 1991; 51: 1076.
  • 3
    Wong H, Chang TM. The viability and regeneration of artificial cell microencapsulated rat hepatocyte xenograft transplants in mice. Biomater Artif Cells Artif Organs 1998; 16: 731.
  • 4
    Lanza RP, Jackson R, Sullivan A, Ringeling J, McGrath C, Chick WL. Xenotransplantation of cells using biodegradable microcapsules. Transplantation 1999; 67: 1105.
  • 5
    Takebe K, Shimura T, Munkhbat B, Hagihara M, Nakanishi H, Tsuji K. Xenogeneic (pig to rat) fetal liver fragment transplantation using macrocapsules for immunoisolation. Cell Transplant 1996; 5: S31.
  • 6
    Gomez N, Balladur P, Calmus Y, et al. Evidence for survival and metabolic activity of encapsulated xenogeneic hepatocytes transplanted without immunosuppression in Gunn rats. Transplantation 1997; 63: 1718.
  • 7
    Sarkis R, Wen L, Honiger J, et al. Intraperitoneal transplantation of isolated hepatocytes of the pig: the implantable bioartificial liver. Chirurgie 1998; 123: 41.
  • 8
    Korbutt GS, Ao Z, Flashner M, Elliott JF, Rajotte RV. Coencapsulation of allogeneic islets with allogeneic Sertoli cells prolongs graft survival without systemic immunosuppression. Transplant Proc 1998; 30: 419.
  • 9
    Yang H, Wright J Jr. Co-encapsulation of Sertoli enriched testicular cell fractions further prolongs fish-to-mouse islet xenograft survival. Transplantation 1999; 67: 815.
  • 10
    Selawry HP, Cameron DF. Sertoli cell enriched fractions in successful islet cell transplantation. Cell Transplant 1993; 2: 123.
  • 11
    Willing AE, Othberg AI, Saporta S, et al. Sertoli cells enhance the survival of co-transplanted dopamine neurons. Brain Res 1999; 822: 246.
  • 12
    Sanberg PR, Saporta S, Borlongan CV, Othberg AI, Allen RC, Cameron DF. The testis-derived cultured Sertoli cell as a natural Fas-L secreting cell for immunosuppressive cellular therapy. Cell Transplant 1997; 6: 191.
  • 13
    Koji T, Hishikawa Y, Ando H, Nakanishi Y, Kobayashi N. Expression of Fas and Fas ligand in normal and ischemia-reperfusion testes: involvement of the Fas system in the induction of germ cell apoptosis in the damaged mouse testis. Biol Reprod 2001; 64: 946.
  • 14
    Suarez-Pinzon W, Korbutt GS, Power R, Hooton J, Rajotte RV, Rabinovitch A. Testicular Sertoli cells protect islet beta-cells from autoimmune destruction in NOD mice by a transforming growth factor-beta1-dependent mechanism. Diabetes 2000; 49: 1810.
  • 15
    Selden C, Roberts E, Stamp G, et al. Comparison of three solid phase supports for promoting three- dimensional growth and function of human liver cell lines. Artif Organs 1998; 22: 308.
  • 16
    Khalil M, Shariat-Panahi A, Tootle R, et al. Human hepatocyte cell lines proliferating as cohesive spheroid colonies in alginate markedly upregulate both synthetic and detoxificatory liver function. J Hepatol 2001; 34: 68.
  • 17
    King GA, Daugulis AJ, Faulkner P, Goosen MF. Alginate-polylysine microcapsules of controlled membrane molecular weight cut-off for mammalian cell culture engineering. Biotechnol Prog 1987; 13: 231.
  • 18
    Galdieri M, Monaco L, De Martino C. Morphological and biochemical effects of lonidamine on cultured Sertoli cells. Exp Mol Pathol 1984; 41: 202.
  • 19
    Onoda M, Suarez-Quian CA, Djakiew D, Dym M. Characterization of Sertoli cells cultured in the bicameral chamber system: relationship between formation of permeability barriers and polarized secretion of transferrin. Biol Reprod 1990; 43: 672.
  • 20
    Rozga J. Hepatocyte proliferation in health and in liver failure. Med Sci Monit 2002; 8: RA32.
  • 21
    Shi Q, Gaylor JD, Cousins R, Plevris J, Hayes PC, Grant MH. The effects of serum from patients with acute liver failure on the growth and metabolism of HepG2 cells. Artif Organs 1998; 22: 1023.
  • 22
    McCloskey P, Tootle R, Selden C, Larson F, Roberts E, Hodgson HJ. Modulation of hepatocyte function in an immortalized human hepatocyte cell line following exposure to liver-failure plasma. Artif Organs 2002; 26: 340.
  • 23
    Catizone A, Ricci G, Galdieri M. Expression and functional role of hepatocyte growth factor receptor (C-MET) during postnatal rat testis development. Endocrinology 2001; 142: 1828.
  • 24
    Nakamura J, Okamoto T, Schumacher IK, et al. Treatment of surgically induced acute liver failure by transplantation of conditionally immortalized hepatocytes. Transplantation 1997; 63: 1541.
  • 25
    Dixit V, Darvasi R., Arthur M, Brezina M, Lewin K, Gitnick G. Restoration of liver function in Gunn rats without immunosuppression using transplanted microencapsulated hepatocytes. Hepatology 1990; 12: 1342.
  • 26
    Bellgrau D, Gold D, Selawry H, Moore J, Franzusoff A, Duke RC. A role for CD95 ligand in preventing graft rejection. Nature 1995; 377: 630.
  • 27
    D'Alessio A, Riccioli A, Lauretti P, et al. Testicular FasL is expressed by sperm cells. Proc Natl Acad Sci USA 2001; 98: 3316.
  • 28
    Brouazin-Jousseaume V, Guitton N, Legue F, Chenal C. GSH level and IL-6 production increased in Sertoli cells and astrocytes after gamma irradiation. Anticancer Res 2002; 22: 257.
  • 29
    Mullaney BP, Skinner MK. Basic fibroblast growth factor (bFGF) gene expression and protein production during pubertal development of the seminiferous tubule: follicle-stimulating hormone-induced Sertoli cell bFGF expression. Endocrinology 1992; 131: 2928.
  • 30
    Liu ZC, Chang TM. Increased viability of transplanted hepatocytes when hepatocytes are co-encapsulated with bone marrow stem cells using a novel method. Artif Cells Blood Substit Immobil Biotechnol 2002; 30: 92.